AMERICAN PHARMACISTS ASSOCIATION for AMERICAN PHARMACISTS ASSOCIATION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR756/S660 - National Pain Care Policy Act of 2009 HR179 - Community AIDS and Hepatitis Prevention Act S1213 - A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research. HR2891 - Access to Frontline Health Care Act of 2009 HR1259 - The Dextromethorphan Distribution Act of 2009 HR1256 - Family Smoking Prevention and Tobacco Control Act on S.A. 1229 - Pharmaceutical Market Access and Drug Safety Act of 2009 (Docket Number: IRS-2006-0502) Employer Comparable Contributions to Health Savings Accounts Under Section 4980G (74 FR 28937) Draft Recommendations for the Term Meaningful Use" of Electronic Health RecordsConcept (Docket Number 105A) Updating the List of Hazardous Drugs for the NIOSH Alert: Additions and Deletions to the NIOSH Hazardous Drug List Concept (No Bill Language) Utilizing E-Prescribing Technologies to Integrate Pharmacogenomics into Prescribing and Dispensing Practices Concept (No Bill Language) CBO Scoring of Prevention and Chronic Disease Management in Health Care Reform Draft Bill Access to Birth Control Act Draft Bill Affordable Health Choices Act (Sections on ensuring quality of care; affordable choices of health benefit plans; seeking the best medical advice; spending for Federally Qualified Health Centers (FQHCs); national strategy; presentation of drug information; center for health outcomes research and evaluation; administrative simplification; right choices program; grants to establish community health teams to support a medical home model; grants to implement medication management services in treatment of chronic disease; national health care workforce commission; funding for National Health Service Corps; geriatric education and training, career awards, comprehensive geriatric education; nurse education, practice, and retention grants; and increase prevention and wellness provisions) Draft Bill - America's Affordable Health Choices Act of 2009 HR3200 [(no bill name or number during reporting period) Sections on ensuring adequacy of provider networks; essential benefits package defined; Health Benefits Advisory Committee; outreach and enrollment of Exchange-eligible individuals and employers in Exchange-participating health benefits plan; payment rates for items and services; reducing potentially preventable hospital readmissions; post acute care services payment reform plan; requiring drug manufacturers to provide drug rebates for certain, full premium subsidy eligible individuals; phasedin elimination of coverage gap; repeal of provision relating to submission of claims by pharmacies located in or contracting with long-term care facilities; including costs incurred by AIDS drug assistance programs and Indian Health Service in providing prescription drugs toward the annual out of pocket threshold under part D; permitting mid-year changes in enrollment; telehealth expansion and enhancements; intelligent assignment in enrollment; ensuring effective communication in Medicare; Accountable Care Organization pilot program; medical home pilot program; coverage and waiver of cost-sharing for preventive services; comparative effectiveness research; reports on financial relationships between manufacturers and distributors of covered drugs, devices, biologicals, or medical supplies under Medicare, Medicaid, or CHIP and physicians and other health care entities and between physicians and other health care entities; distribution of unused residency positions; require providers and suppliers to adopt programs to reduce waste, fraud, and abuse, payments to pharmacists; Task Force on Clinical Preventive Services; fully integrated dual eligible special needs plans (FIDESNP); public health and workforce development; prevention and wellness; and sections 212 (grants to establish community health teams to support a medical home model) and 213 (grants to implement medication management services in treatment of chronic disease) from the Senate HELP Committee's Draft Affordable Health Choices Act] Commented on Senate Finance Committee Report on Expanding Health Care Coverage and Senate Finance Committee Report on Transforming the Health Care Delivery System Concept Role of Pharmacist-Provided Patient Care Services in any Integrated Care Model and Medication Therapy Management Services in Health Care Reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARCIE BOUGH | Former Legislative Assistant |
| KRISTINA E LUNNER | — |
Budget/Appropriations BUD
(Public Law 111-5) American Recovery and Reinvestment Act of 2009 Sections on Health Information Technology
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARCIE BOUGH | Former Legislative Assistant |
| KRISTINA E LUNNER | — |
Medicare/Medicaid MMM
HR616/S511 - Access to Durable Medical Equipment Act HR203 - Medicare Fraud Prevention Act of 2009 HR27 - Medicare Fraud Prevention and Enforcement Act of 2009 HR574 - Medicare Home Infusion Therapy Coverage Act of 2009 S266 - Medicare Prescription Drug Gap Reduction Act of 2009 HR2560/S1131 - Independence At Home Act HR1970/S956 - Preserve Patient Access to the Reputable DMEPOS Providers Act of 2009 HR3700/S1951 - Fair Medicaid Drug Payment Act (From 110th Congress)/Concept to Include Medicaid Average Manufacturer Price Reimbursement Formula in Health Care Reform (Public Law 110-275) Medicare Improvements for Patients and Providers Act of 2008 Sections on Medicare DMEPOS (Docket Number: CMS1561IFC) Medicare Program; Changes to the Competitive Acquisition of Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) by Certain Provisions of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) (Docket Number: CMS-1540-F) Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2007; Certain Provisions Concerning Competitive Acquisition for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS); Accreditation of DMEPOS Suppliers (Docket Number: CMS-6006-F) Medicare Program: Surety Bond Requirement for Suppliers of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Solicitation for Comments on the Draft CMS Model Transition Letter for Calendar Year 2010 Draft 2010 Medicare Part D Call Letter
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARCIE BOUGH | Former Legislative Assistant |
| KRISTINA E LUNNER | — |
Pharmacy PHA
HR1204 - The Community Pharmacy Fairness Act of 2009 S80 - Pharmaceutical Market Access Act of 2009 S525/HR1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR163 - Prescription Drug Affordability Act HR2400 - Strategies to Address Antimicrobial Resistance Act HR1706 - Protecting Consumer Access to Generic Drugs Act of 2009 (Docket No. DEA322I) Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (Docket No. FDA2009N0143) Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs; Notice of Public Meeting (Docket Number: FDA-2008-P-0380) Citizen Petition: Requesting a FDA Action on a "One Document Solution" for all Pharmacy-Based Communications (Docket Number FDA2008N0038) Risk Communication Advisory Committee; Notice of Meeting (focused on the types of communications that patients receive at the pharmacy includes: medication guides; patients package inserts; and consumer medication information) (Docket Number: FDA2009D0001) Draft Guidance for Industry on Standards for Securing the Drug Supply ChainStandardized Numerical Identification for Prescription Drug Packages; Availability (Docket Number: FDA-2008-S-0627) Expert and Consumer Evaluation of Consumer Medication Information -- 2008 (Docket No. FDA1977N0013) (formerly Docket No. 1977N0094L) Organ-Specific Warnings; Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Final Monograph (Docket No. FDA2009D0181) Draft Guidance for Industry on Label Comprehension Studies for Nonprescription Drug Products; Availability (Docket No. FDA2009N0138) Joint Meeting of the Drug Safety and Risk Management Advisory Committee, Nonprescription Drugs Advisory Committee, and the Anesthetic and Life Support Drugs Advisory Committee; Notice of Meeting
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARCIE BOUGH | Former Legislative Assistant |
| KRISTINA E LUNNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.